Silk Road Medical Inc. (SILK) Misses Q4 EPS by 6c, Revenues Beats

Silk Road Medical Inc. (NASDAQ: SILK) reported Q4 EPS of ($0.42), $0.06 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $28.3 million versus the consensus estimate of $25.9 million.

GUIDANCE:

Silk Road Medical Inc. sees FY2022 revenue of $126-132 million, versus the consensus of $133.39 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79